Selvan Ravindran
Selvan Ravindran
Symbiosis School of Biomedical Sciences, Symbiosis International University
Verified email at - Homepage
Cited by
Cited by
Pharmacokinetics, metabolism, distribution and permeability of nanomedicine
S Ravindran, JK Suthar, R Rokade, P Deshpande, P Singh, A Pratinidhi, ...
Current drug metabolism 19 (4), 327-334, 2018
Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons
S Ravindran, OL Zharikova, RA Hill, TN Nanovskaya, GDV Hankins, ...
Biochemical pharmacology 72 (12), 1730-1737, 2006
Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon
OL Zharikova, S Ravindran, TN Nanovskaya, RA Hill, GDV Hankins, ...
Biochemical pharmacology 73 (12), 2012-2019, 2007
Monoclonal antibody purification and its progression to commercial scale
DS Chahar, S Ravindran, SS Pisal
Biologicals 63, 1-13, 2020
Macroscopic synthesis and characterization of giant fullerenes
R Selvan, R Unnikrishnan, S Ganapathy, T Pradeep
Chemical Physics Letters 316 (3-4), 205-210, 2000
Toxic implications of silver nanoparticles on the central nervous system: a systematic literature review
JK Suthar, A Vaidya, S Ravindran
Journal of Applied Toxicology 43 (1), 4-21, 2023
Investigations on the growth of anthracene and trans-stilbene single crystals using vertical Bridgman technique
A Arulchakkaravarthi, CK Lakshmanaperumal, P Santhanaraghavan, ...
Materials Science and Engineering: B 95 (3), 236-241, 2002
Significance of biotransformation in drug discovery and development
S Ravindran, S Basu, P Surve, G Lonsane, N Sloka
J Biotechnol Biomater S 13, 2012
Towards the synthesis and characterization of metallocarbohedrenes
R Selvan, T Pradeep
Chemical physics letters 309 (3-4), 149-156, 1999
Nanomedicine: Bioavailability, biotransformation and biokinetics
S Ravindran, AJ Tambe, JK Suthar, DS Chahar, JM Fernandes, V Desai
Current drug metabolism 20 (7), 542-555, 2019
Production of Biosurfactant Stabilized Nanoparticles
S Pooja, R Selvan, ...
International Journal of Pharma and Bio Sciences 8 (2), 701-707, 2017
Metabolic profile of glyburide in human liver microsomes using LC‐DAD‐Q‐TRAP‐MS/MS
S Ravindran, S Basu, SKK Gorti, P Surve, N Sloka
Biomedical Chromatography 27 (5), 575-582, 2013
Metallocarbohedrenes: recent advancements
R Selvan, T Pradeep
Current Science, 666-680, 1998
Translational drug discovery research: Integration of medicinal chemistry, computational modeling, pharmacology, ADME, and toxicology
S Vangala, J Pinjari, P Patole, S Ravindran, R Gangal, P Wangikar, ...
Encyclopedia of drug metabolism and interactions, 1-54, 2011
Reactive ion scattering spectrometry of mixed methyl-and hydroxy-terminated alkanethiolate self-assembled monolayers
DL Smith, R Selvan, VH Wysocki
Langmuir 19 (18), 7302-7306, 2003
Antibiotics functionalization intervened morphological, chemical and electronic modifications in chitosan nanoparticles
MM Shirolkar, R Athavale, S Ravindran, V Rale, A Kulkarni, R Deokar
Nano-Structures & Nano-Objects 25, 100657, 2021
Metabolite characterization of anti-cancer agent gefitinib in human hepatocytes
P Surve, S Ravindran, A Acharjee, H Rastogi, S Basu, P Honrao
Drug Metabolism Letters 7 (2), 126-136, 2013
Glyburide metabolism by placentas of healthy and gestational diabetics
S Jain, OL Zharikova, S Ravindran, TN Nanovskya, DR Mattison, ...
American journal of perinatology 25 (03), 169-174, 2008
Purification of nanoparticles by liquid chromatography for biomedical and engineering applications
JK Suthar, R Rokade, A Pratinidi, R Kambadkar, S Ravindran
American Journal of Analytical Chemistry 8 (10), 617-624, 2017
Optimal use of mass spec scan modes to characterize an unknown metabolite.
S Ravindran, CH Rao, R Sahu, A Basit, S Madireddy, S Basu, S Vangala
Drug Invention Today 3 (10), 2011
The system can't perform the operation now. Try again later.
Articles 1–20